Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy

Anaesthesia Critical Care and Pain Medicine

Volumn 36, Issue 1, 2017, Pages 39-42

  Labbene, I ^a   Arrigo, M ^b   Tavares, M ^c   Hajjej, Z ^a   Brandao J L ^c   Tolppanen, H ^b   Feliot, E ^b   Gayat, E ^b,d   Ferjani, M ^a   Mebazaa, A ^b,d  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

^b AP HP Saint Louis and Lariboisière University Hospitals   (France)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cardiogenic shock; Congestion; Inotropic agents; Levosimendan; Postpartum cardiomyopathy

Indexed keywords

CATECHOLAMINE; DOBUTAMINE; EPINEPHRINE; INOTROPIC AGENT; LEVOSIMENDAN; LOOP DIURETIC AGENT; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MONITORING; ELECTROCARDIOGRAPHY; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM PRESSURE; HUMAN; INDWELLING CATHETER; LOADING DRUG DOSE; PERIPARTUM CARDIOMYOPATHY; PULMONARY ARTERY CATHETER; PULMONARY ARTERY OCCLUSION PRESSURE; RETROSPECTIVE STUDY; URINE VOLUME; AGED; BLOOD PRESSURE; CARDIOMYOPATHY; CATHETERIZATION; COMPLICATION; DIAGNOSTIC IMAGING; DRUG EFFECTS; ECHOCARDIOGRAPHY; HEART ATRIUM FUNCTION; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PUERPERIUM; PULMONARY ARTERY; SHOCK, CARDIOGENIC;

ADULT; AGED; ATRIAL FUNCTION, RIGHT; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; CATHETERIZATION; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; POSTPARTUM PERIOD; PULMONARY ARTERY; PYRIDAZINES; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; STROKE VOLUME;

EID: 84985883054     PISSN: None     EISSN: 23525568     Source Type: Journal    
DOI: 10.1016/j.accpm.2016.02.009     Document Type: Article

References (21)

1. [1] Hilfiker-Kleiner, D., Haghikia, A., Nonhoff, J., Bauersachs, J., Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 36 (2015), 1090–1097.
2. [2] Schroeter, M.R., Unsöld, B., Holke, K., Schillinger, W., Prothrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump. Clin Res Cardiol 102 (2013), 155–157.
3. [3] Cecconi, M., De Backer, D., Antonelli, M., Beale, R., Bakker, J., Hofer, C., et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European society of intensive care medicine. Intensive Care Med 40 (2014), 1795–1815.
4. [4] Stapel, B., Kohlhaas, M., Ricke-Hoch, M., Haghikia, A., Erschow, S., Knuuti, J., et al. Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J, 2016, ehw086.
5. [5] Benlolo, S., Lefoll, C., Katchatouryan, V., Payen, D., Mebazaa, A., Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg 98 (2004), 822–824.
6. [6] Uriarte-Rodríguez, A., Santana-Cabrera, L., Sánchez-Palacios, M., Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy. J Emerg Trauma Shock, 3, 2010, 94.
7. [7] Scardovi, A.B., De Maria, R., Ricci, R., Acute peripartum cardiomyopathy rapidly evolving in cardiogenic shock. Intern J Cardiol 189 (2015), 255–256.
8. [8] Brogly, N., Guasch, E., Puertas, L., Alsina, E., López, T., Gilsanz, F., Défaillance cardiaque aiguë associée à une cardiomyopathie dilatée en post-partum précoce : traitement par ballon de contrepulsion aortique et lévosimendan. Ann Fr Anesth Reanim 29 (2010), 807–810.
9. [9] Nieto Estrada, V.H., Molano Franco, D.L., Valencia Moreno, A.A., Rojas Gambasica, J.A., Jaller Bornacelli, Y.E., Martinez Del Valle, A., Reversion of severe mitral insufficiency in peripartum cardiomyopathy using levosimendan. J Clin Med Res 7 (2015), 998–1001.
10. [10] Vincent, J.L., De Backer, D., Circulatory shock. N Engl J Med 369 (2013), 1726–1734.
11. [11] Sliwa, K., Hilfiker-Kleiner, D., Petrie, M.C., Mebazaa, A., Pieske, B., Buchmann, E., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart failure association of the European society of cardiology working group on peripartum cardiomyopathy. Eur J Heart Fail 12 (2010), 767–778.
12. [12] Haikala, H., Pollesello, P., Calcium sensitivity enhancers. Drugs 3 (2000), 1199–1205.
13. [13] Sorsa, T., Heikkinen, S., Abbott, M.B., Abusamhadneh, E., Laakso, T., Tilgmann, C., et al. Binding of levosimendan, a calcium sensitizer, to cardiac troponin C. J Biol Chem 276 (2001), 9337–9343.
14. [14] Kaheinen, P., Pollesello, P., Levijoki, J., Haikala, H., Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart. J Cardiovasc Pharmacol 43 (2004), 555–561.
15. [15] Levijoki, J., Pollesello, P., Kaivola, J., Tilgmann, C., Sorsa, T., Annila, A., et al. Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan. J Mol Cell Cardiol 32 (2000), 479–491.
16. [16] Janssen, P.M., Datz, N., Zeitz, O., Hasenfuss, G., Levosimendan improves diastolic and systolic function in failing human myocardium. Eur J Pharmacol 404 (2000), 191–199.
17. [17] Kopustinskiene, D.M., Pollesello, P., Saris, N.E., Levosimendan is a mitochondrial K(ATP) channel opener. Eur J Pharmacol 428 (2001), 311–314.
18. [18] Kaheinen, P., Pollesello, P., Levijoki, J., Haikala, H., Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels. J Cardiovasc Pharmacol 37 (2001), 367–374.
19. [19] Delle Karth, G., Buberl, A., Geppert, A., Neunteufl, T., Huelsmann, M., Kopp, C., et al. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 47 (2003), 1251–1256.
20. [20] Russ, M.A., Prondzinsky, R., Christoph, A., Schlitt, A., Buerke, U., Söffker, G., et al. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 35 (2007), 2732–2739.
21. [21] Biteker, M., Duran, N.E., Kaya, H., Gündüz, S., Tanboğa Hİ, Gökdeniz, T., et al. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol 100 (2011), 571–577.